All companies
Visit website
TruBrain
OperatingTriplePulse, Inc.
Healthcare · Founded 2012
Brain Food just got smarter. TruBrain + CBD
Post-money valuation ⓘ
$30.5M
As of Aug 2026 · from Reg CF Offering (2026) · pre-money + amount raised, not a traded price
Total raised
$4,198,020
Across 5 rounds since 2019
Latest share price
$0.43
Reg CF Offering (2026) offering price
Financials
FY2017–FY2025 · from SEC filings · hover any figure for its source$2.7M
−$582K
2018
$1.9M
$18K
2019
$1.6M
−$70K
2020
$2.1M
$73K
2021
$2.5M
$140K
2022
$2.7M
$93K
2023
$2.4M
−$50K
2024
$2.3M
−$243K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Chart shows the most recent 8 fiscal years; 1 earlier year is in the table below.
Metric
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$2,960,790
$2,749,416
$1,942,633
$1,593,720
$2,139,169
$2,474,138
$2,720,714
$2,408,637
$2,290,808
Cost of goods sold
$1,782,466
$166,360
$886,539
$777,472
$959,151
$922,228
$1,319,691
$1,045,617
$1,081,171
Gross margin
40%
94%
54%
51%
55%
63%
51%
57%
53%
Net income
-$401,071
-$581,885
$17,811
-$70,492
$73,257
$140,422
$92,911
-$50,208
-$243,086
Taxes paid
$1,006
$800
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$321,867
$185,965
$783,147
$902,844
$1,284,276
$1,012,451
$1,318,763
$1,524,584
$890,853
Accounts receivable
$0
$0
$0
$0
$0
$0
$0
$0
$0
Total assets
$559,917
$359,284
$1,142,520
$1,236,196
$1,583,825
$1,938,882
$2,253,191
$2,155,996
$1,789,693
Short-term debt
$0
$542,014
$850,000
$853,655
$756,141
$711,141
$279,456
$248,689
$125,472
Long-term debt
$1,455,000
$1,455,000
$0
$146,345
$113,859
$232,660
$217,074
$195,000
$195,000
Total liabilities
$1,455,000
$1,997,014
$1,384,341
$1,000,000
$870,000
$943,801
$496,530
$443,689
$320,472
Other
Headcount
—
4
4
2
4
2
2
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$20.0M
post-money
$19.1M
post-money
$25.9M
post-money
$30.5M
post-money
TruBrain Stock 1
TruBrain Stock 2
Reg CF Offering (2022-06-18)
Reg CF Offering (2026)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $15.2K / $5MInvestors 10Post-money $30.5M
Raised $1.6MInvestors 1,298Post-money $25.9M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 5 of 7 annual reports (FY2019–FY2025)
1,605 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 46 filings on EDGARSource: ManualCIK 0001603707Share price $0.43
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.